Abecma®
Company
Bluebird Bio, Bristol-Myers Squibb
Use
Treatment of relapsed or refractory multiple myeloma.
Features
CAR T-cell therapy for patients with multiple myeloma.
NIH Contribution
Development of CAR T-cell technology enabling BCMA-targeted CAR-T therapy.
HHS Institute/Agency
NCI
Inventor(s)
Kochenderfer, J. et al.
Year
2021
